1. The natural killer cell immunotherapy platform: An overview of the landscape of clinical trials in liquid and solid tumors
   Sara Piccinelli et al, 2023, Seminars in Hematology CrossRef
2. Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer
   Xianwen Hu et al, 2022, Frontiers in Oncology CrossRef
3. SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers
   Zhen Lu et al, 2022, Journal of Clinical Investigation CrossRef
4. BRCA Mutations and PARP Inhibitors in Breast and/or Ovarian Cancer Patients
   Abdulrahim Gari et al, 2021, International Journal Of Pharmaceutical Research And Allied Sciences CrossRef
5. The Molecular Mechanisms of Actions, Effects, and Clinical Implications of PARP Inhibitors in Epithelial Ovarian Cancers: A Systematic Review
   Chien-Hui Lau et al, 2022, International Journal of Molecular Sciences CrossRef
6. Peripheral Neuropathy under Oncologic Therapies: A Literature Review on Pathogenetic Mechanisms
   Mariarita Laforgia et al, 2021, International Journal of Molecular Sciences CrossRef
7. Prevalence of Clinically Relevant Germline BRCA Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience
   Nerina C. Van der Merwe et al, 2022, Frontiers in Genetics CrossRef
8. Small-Molecule–Mediated Stabilization of PP2A Modulates the Homologous Recombination Pathway and Potentiates DNA Damage-Induced Cell Death
   Rita A. Avelar et al, 2023, Molecular Cancer Therapeutics CrossRef
9. Targeted inhibition of the ATR/CHK1 pathway overcomes resistance to olaparib and dysregulates DNA damage response protein expression in BRCA2MUT ovarian cancer cells
   Łukasz Biegała et al, 2023, Scientific Reports CrossRef
10. Niraparib treatment for patients with BRCA-mutated ovarian cancer: review of clinical data and therapeutic context
    Antonio González-Martín et al, 2022, Future Oncology CrossRef
11. Synergistic cytotoxicity of irinotecan combined with polysaccharide-based nanoparticles for colorectal carcinoma
    Fang-Ting Pai et al, 2023, Biomaterials Advances CrossRef
12. Machine Learning Quantification of Intraepithelial Tumor-Infiltrating Lymphocytes as a Significant Prognostic Factor in High-Grade Serous Ovarian Carcinomas
    Jesús Machuca-Aguado et al, 2023, International Journal of Molecular Sciences CrossRef
13. Homologous Recombination Deficiencies and Hereditary Tumors
    Hideki Yamamoto et al, 2021, International Journal of Molecular Sciences CrossRef
14. Expression of PAWR predicts prognosis of ovarian cancer
    Jiahong Tan et al, 2020, Cancer Cell International CrossRef